Abstract:SUMMARYCholera vibrios can be allocated to one of three biotypes (classical, intermediate and El Tor), each of which can be sub-divided into two serotypes (Ogawa and Inaba). Vibriocidal tests with absorbed antisera have shown no evidence of biotype specificity in the killing of bacteria, but they have confirmed the role of the two serotype-specific antigens in immunity to cholera. The same presence of serotype specificity, and absence of biotype specificity, has been found by bacterial agglutination, an easier… Show more
“…Antisera raised in rabbits showed that the Inaba serum displayed weaker vibriocidal activity compared to that produced by the Ogawa serum [86,136]. This agrees with the human response to cholera vaccines as a weaker Inaba vibriocidal response was detected in comparison to the Ogawa vibriocidal response [88,137].…”
Section: The Vaccine Should Comprise Both the Ogawa And Inaba Serotypessupporting
“…Antisera raised in rabbits showed that the Inaba serum displayed weaker vibriocidal activity compared to that produced by the Ogawa serum [86,136]. This agrees with the human response to cholera vaccines as a weaker Inaba vibriocidal response was detected in comparison to the Ogawa vibriocidal response [88,137].…”
Section: The Vaccine Should Comprise Both the Ogawa And Inaba Serotypessupporting
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.